Identification of a κ-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis

Phenotypic screening of the LOPAC library identified several potent and selective inhibitors of African trypanosomes. The κ-opioid agonist (+)-U50,488 represents a novel lead for drug discovery against sleeping sickness.